Hope for new Scottish drug which shows promise in fight against Covid-19

The successful studies involved both treating infection and blocking new infections.

Scientists hope to begin clinical tests of a new anti-viral drug which has had positive results in laboratory tests against Covid-19.

Pneumagen, a University of St Andrews spin-out company, carried out three separate in-vitro studies into preventing coronavirus infections, including Sars-CoV-2 infection, the cause of Covid-19, using Neumifil and multivalent Carbohydrate Binding Modules (mCBMs) generated using its GlycoTarge technology.